BioSpace News Archive

Sema4 today announced that Eric Schadt , Ph.D., Founder and Chief Executive Officer, and Isaac Ro , Chief Financial Officer will participate at the following virtual investor conferences: Wells Fargo Securities Healthcare Conference Fireside chat on Friday, September 10th at 8:40 a.m. ET

Avantor, Inc. announced that it will host a virtual investor day on September 9, 2021 starting at 9:00 a.m. Eastern Daylight Time .

Novavax, Inc. today announced that the U.S. Centers for Disease Control and Prevention (CDC) has provided updated guidance for those who have been vaccinated as part of a clinical trial in the U.S.

Adamas Pharmaceuticals, Inc. today announced that management will present at the virtual investor conferences during the month of September 2021

Talis Biomedical Corporation today announced that effective immediately Brian Coe has stepped down as President, CEO and Director and will continue to work with the company as an advisor. The company also announced that Kim Popovits has been appointed as interim CEO

Global Cord Blood Corporation (NYSE: CO) (“GCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for the first quarter of fiscal 2022, ended June 30, 2021.

Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced it will present at the 2021 Virtual Wells Fargo Healthcare Conference via web cast. Christian Gormsen, Eargo’s President and Chief Executive Officer, is scheduled to present on Thursday, September 9th at 3:20 p.m. Eastern Time (12:20 p.m. Pacific Time).

Theralase® Technologies Inc. has released the Company’s unaudited Q22021 condensed interim consolidated financial statements and Quarterly Newsletter which provides updates on the previous quarter and progress on the Phase II Non-Muscle Invasive Bladder Cancer Clinical Study.

Braxia Scientific Corp. (“Braxia Scientific,” or the “Company”), (CSE: BRAX) (OTC: BRAXF) (FWB: 496), a medical research company with clinics providing innovative ketamine treatments for persons with depression and related disorders, today announced the filing of its fiscal first-quarter results for the three-month period ending June 30, 2021.

The number of solid organ transplants performed during the first wave of COVID-19 in 2020 plunged by 31% compared to the previous year, according to a new global study presented at the European Society for Organ Transplantation (ESOT) Congress 2021.